Search CommunityWalk:


BHR Pharma, LLC.

607 Herndon Parkway, Suite 110
Herndon, VA 20170, USA

Category: Drug Delivery

Used in the following map:

Maryland Biotech Industry Map

BHR Pharma, LLC. is a pharmaceutical research & development company committed to bringing to market products using non-oral delivery systems with an emphasis on unmet and underserved medical needs. The company was founded in January 2008 with a mission to develop a robust pipeline of specialty drugs focusing on unmet medical needs. It's a wholly-owned subsidiary of Besins Healthcare.

BHR Pharma's, Enhanced Hydroalcoholic Gel (EHG®) technology is transdermal delivery system that avoids the gut and first-pass liver metabolism, increasing bioavailability in many instances and avoiding the generation of potentially toxic metabolites. The company's development pipeline focuses on products that use the EHG® technology and other parenteral formulations.

BHR Pharma's product pipeline includes: BHR-100 (i.v. progesterone infusion) in treating severe Traumatic Brain Injury patients; BHR-200 (transdermal estradiol gel) for the palliative treatment of advanced androgen-sensitive carcinoma of the prostate and for the treatment of the vasomotor side effects in men undergoing androgen deprivation therapy (ADT) for prostate cancer; and Afimoxifene gel for women with ductal carcinoma in situ (DCIS) of the breast and also as a treatment for gynecomastia, the overdevelopment of breast tissue in males, and associated breast pain. It's a topical gel with most active metabolites of tamoxifen, using Enhanced Hydroalcoholic Gel Technology (EHG(TM)). The gel is directly applied to the breast for transdermal delivery to the breast tissue.

BHR Pharma is an affiliate of Ascend Therapeutics, Inc.